Science

Feb 15, 2025, 10:35

Myeloma Paper of the Day, February 15th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Final analysis of MAIA patient-reported outcomes finds sustained Improvement in health-related quality of life in transplant-ineligible newly diagnosed myeloma treated with daratumumab/len/dex vs. len/dex doublet.”

“Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: MAIA Final Analysis of Patient-Reported Outcomes”

Authors: Aurore Perrot, Thierry Facon, Torben Plesner, Fredrik Borgsten, Katja Weisel et al.

More posts featuring Robert Orlowski.

Aurore Perrot cancer Fredrik Borgsten Katja Weisel multiple myeloma Myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Thierry Facon Torben Plesner

New Paper Alert: Management of Immune Checkpoint Inhibitor-Associated Toxicities in Older Adults with Cancer

Kimryn Rathmell was Awarded 2025 ACS Medal of Honor

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!